Growth Without the Blind Spots: Managing Risk Across the M&A Lifecycle
Presented By: Lockton / Shutts & Bowen
Growth through acquisition creates opportunity—but it can also expose risks that follow a company long after the deal closes. Hear from business leaders and experienced advisers as they explore how buyers identify and mitigate financial, legal, operational and people-related risks from diligence through integration, where hidden exposures can derail value creation, and how a more disciplined approach to risk can help acquirers protect the upside they set out to capture.
Moderator:
Miami Office Managing Partner
Shutts & Bowen
Aliette DelPozo Rodz is the Managing Partner of the Miami office of Shutts & Bowen LLP, where she is Chair of the International Litigation and Arbitration Practice Group and the Cuba Task Force. Aliette serves as lead trial counsel for companies involved in disputes in state and federal courts, in arbitration and before administrative agencies. She handles all aspects of litigation including preliminary and permanent injunction hearings, evidentiary hearings, bench trials, arbitrations and jury trials.
Panelists:
Managing Partner & CEO
Florida Value Partners
Gus Alfonso is the Managing Partner and CEO of Florida Value Partners (“FVP”). He has helped guide the company’s growth from $50M in real estate assets under management in 2008 to over $1 billion in acquired assets by 2019 and AUM of over $1.3 billion, including an investment portfolio that spans 11 U.S States.
Mr. Alfonso has managed several high-profile acquisitions, including FVP’s 2012 acquisition of a 3,400-unit multifamily portfolio from LNR and the acquisition of the John Hancock Center in Chicago. He is also responsible for managing the acquisition of over 7,000 units of value-add multifamily investments and FVP’s participation in the development of over 1,000 residential units in the South Florida area.
Senior Vice President & Private Equity Practice Leader
Lockton
Josh is Senior Vice President and Private Equity Practice Leader for the Southeast Series of Lockton. In managing the private equity strategy, Josh and his team are responsible for all phases of the PE life cycle. This includes the due diligence phase, reps and warranties insurance, pre-closing insurance coordination, post-close portfolio management and value creation, and preparing for exit. Josh focusses on aligning risk management programs with his client’s operations, goals and objectives, while seeking the most cost efficient solutions in the market as a means to increase EBITDA. The solutions Josh and his team provides goes beyond the typical insurance placement/transaction, and includes alternative risk, strategic claims and loss control support, benchmarking, and the use of data analytics to make informed decisions.
Managing Partner, Big Room Holdings
Former Owner & CEO, National Test Systems
Andrew Panico is the Managing Partner of Big Room Holdings, LLC, a private investment firm focused on acquiring and operating an established lower-middle-market business. He brings experience as an entrepreneur, CEO, investor and finance professional, with a particular interest in partnering with owners who care about the long-term success of their companies, employees and customers.
In 2017, Andrew led the acquisition of National Test Systems (NTS), a provider of point-of-care diagnostic drug-screening products and services. As CEO, he guided the company’s growth and development into a nationwide organization serving more than 1,500 government, behavioral-health and healthcare facilities. Andrew led NTS until its 2025 acquisition by Premier Biotech, a portfolio company of Align Capital Partners. The transaction expanded Premier’s presence in the government and behavioral-health markets and added NTS’s consultative, knowledge-first service model to the broader Premier platform. Andrew remained involved following the acquisition to support the transition and continued growth of the business.